Courtney Dugan | Head of IR |
Thomas Gad | Founder, President & Interim CEO |
Vignesh Rajah | CMO |
Sue Smith | CCO |
Bo Kruse | CFO |
Alec Stranahan | Bank of America |
Charles Zhu | Guggenheim Securities |
Mike Ulz | Morgan Stanley |
Bill Maughan | Canaccord Genuity |
Tessa Romero | JP Morgan |
Luke Shumway | BMO Capital Markets |
Good morning, and welcome to the Y-mAbs Therapeutics, Inc.’s Earnings Conference Call for the Second Quarter of 2023. At this time, all participants are in a listen-only mode. Instructions for the question-and-answer session will follow after the prepared remarks.
As a reminder, today's conference will be recorded.
I'll now hand it over to Y-mAbs’ Head of IR, Courtney Dugan.